Clinical Trials in Chicago

Showing 10521-10540 of 20,493 trials

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

NCT02411539

The purpose of this study was to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody (mAb), VRC-HIVMAB060-00-AB (VRC01), in adults infected with HIV who were receiving antiretroviral therapy (ART).

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)40 participantsStarted Aug 2015

San Diego, California, United States • Aurora, Colorado, United States • Chicago, Illinois, United States +10 more locations

COMPLETEDPhase 1/22.2 miles

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

NCT00766597

Complications with current HIV antiretroviral therapy have left many children and adolescents with limited therapeutic options due to drug resistance. The purpose of this study is to test the effectiveness and safety of Vicriviroc (VCV), an HIV entry inhibitor and CCR5 co-receptor antagonist.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)9 participantsStarted Aug 2009

San Diego, California, United States • Washington D.C., District of Columbia, United States • Washington D.C., District of Columbia, United States +6 more locations

Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents

Find Trials by Condition in Chicago

Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction

Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women

Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides

Virologic Responses To New Nucleoside Regimens After Prolonged ZDV or ddI Monotherapy

The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS

A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy

DOSE Trial of Opioid Sparing Effect

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis